Skip to main content
. 2021 Oct 13;11:20322. doi: 10.1038/s41598-021-99586-1

Figure 1.

Figure 1

Overview of the sample set (n = 481) used for the study of 3 cancer types. Samples were divided into training (75%) and validation sets (25%). Plasma samples obtained from patients with kidney (n = 119), breast (n = 103) and prostate (n = 67) cancers and healthy controls (n = 192) were included in the study.